Skip to site menu Skip to page content

Daily Newsletter

09 August 2023

Daily Newsletter

09 August 2023

NNI andSiriraj Hospital to improve neurointervention care

The MOU focuses on collaboration in education, research, and sharing best practices in the field.

August 08 2023

The National Neuroscience Institute (NNI) of Singapore and Siriraj Hospital, Thailand, have signed a memorandum of understanding (MOU) to improve neurointervention care in both countries.

The MOU formalises the relationship between the two institutions and focuses on partnerships in education, research, and sharing best practices in the field.

NNI CEO Au Wing Lok said: “Siriraj Hospital was established in 1888. It is the oldest and largest teaching hospital in Thailand, with expertise in multiple specialities, whereas NNI was established in 1999 and focuses on neuroscience care.

“Despite our differences, we share a deep commitment to enhance the standard of care for our patients and this MOU will support both our institutions in this mission.”

The signed MOU between NNI and Siriraj Hospital will allow neurointervention doctors, allied health professionals and nurses to increase their clinical expertise and expand their knowledge in workflow and clinical management.

It was initiated by Siriraj Hospital radiology department chair Anchalee Churojana and NNI neurovascular service co-director Dr Wickly Lee.

The MOU also includes a research component, with the two institutions collaborating on neurointervention stroke management.

Dr Wickly Lee said: “Research collaborations could include combining anonymised data from the two institutions to create large volume data sets.  

“This can be used with emerging technologies to analyse pre-treatment evaluation and outcomes, such as aneurysm rupture risk profiles, to guide treatment decisions and maximise patient outcomes.”

Healthcare companies are hesitant to invest in the metaverse

The COVID-19 pandemic pushed the healthcare industry to rapid digitalization. Increased use of telehealth, telepresence systems, remote diagnostics, predictive AI, and wearable technology is changing how healthcare is delivered and improving patient outcomes. Emerging technologies such as AR and VR are becoming increasingly routine for professional training, surgical assistance, and treatment of psychological and neurological disorders. In the pharma and medical devices industries, AR, VR, and AI are rapidly accelerating drug discovery and manufacturing and generating supply chain efficiencies. New digital opportunities will look to build upon disruptive technologies. However, affordability is a limiting factor to widespread adoption. Per GlobalData estimates, the metaverse market is expected to grow at a CAGR of more than 33% between 2023 and 2030. Although metaverse technologies could reinvent healthcare approaches and bring new experiences to healthcare providers and patients, adoption is still at an early stage. There are currently few use cases in the healthcare industry. The metaverse needs to overcome major challenges for healthcare, including regulation and data privacy concerns. Evidence of proven use cases and participation by a critical mass of users are imperative to drive a shift in metaverse investment.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close